Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Clarity Pharmaceuticals Ltd

Clinical trials sponsored by Clarity Pharmaceuticals Ltd, explained in plain language.

Clarity Pharmaceuticals Ltd CU6 ASX

A radiopharmaceutical company developing targeted cancer therapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 1 Completed 1 Terminated 1

New scan could spot hidden prostate cancer early

Diagnosis Ongoing

This phase 3 study tests a new type of PET scan (64Cu-SAR-bisPSMA) to see if it can better detect prostate cancer that has come back after initial treatment. The study involves 220 adults with a rising PSA level after surgery or radiation. The goal is to improve detection so doct…

Phase: PHASE3 • Sponsor: Clarity Pharmaceuticals Ltd • Aim: Diagnosis

Last updated Jun 27, 2026 12:33 UTC